Why the study?
Are there consistent recommendations for radiopharmaceutical dosing in patients with chronic kidney disease?
Population
Patients with CKD
Design
Systematic review
Authors
Loading...
Requires individualized dosing caution in CKD; leaves open a major evidence gap for dedicated pharmacokinetic studies.
Are there consistent recommendations for radiopharmaceutical dosing in patients with chronic kidney disease?
This systematic review highlights the critical lack of consistent dosing guidelines for radiopharmaceuticals in patients with CKD, emphasizing the need for future studies to address this gap.
Schreuder et al. (2021) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: